1.Maintenance of ovarian function in end-of-life cervical cancer patient following primary surgico-radiotherapy and ovarian transposition.
Renee Vina G SICAM ; Kuan Gen HUANG ; Yung Chia CHANG ; Chyi Long LEE
Journal of Gynecologic Oncology 2013;24(2):204-207
A 35-year-old woman underwent laparoscopic radical hysterectomy, pelvic lymphadenectomy and ovarian transposition for stage IB2 cervical adenocarcinoma. She received adjuvant concurrent chemoradiation for poor pathologic risk factors but had tumor recurrence 20 months after the surgery. Transposed ovaries were uninvolved in the recurrence and progression. Salvage chemotherapy and radiotherapy were given. Despite systemic chemotherapy and repeat pelvic radiotherapy, the patient was able to maintain ovarian function. Ovarian transposition in cervical cancer is an easily performed procedure that does not alter the prognosis of the disease in some cases. Present recommendations for its use should be reevaluated so that more premenopausal cancer patients may benefit from this underutilized procedure.
Adenocarcinoma
;
Female
;
Humans
;
Hysterectomy
;
Laparoscopy
;
Lymph Node Excision
;
Ovary
;
Prognosis
;
Quality of Life
;
Recurrence
;
Risk Factors
;
Uterine Cervical Neoplasms
2.Mullerian adenosarcoma with sarcomatous overgrowth in a premenopausal patient
Celeste Zamuco-Francisco ; Renee Vina G. Sicam
Philippine Journal of Obstetrics and Gynecology 2020;44(3):44-48
We report a case of a 33-years old, nulligravid, diagnosed with mullerian adenosarcoma with sarcomatous overgrowth (MASO), who presented with vaginal bleeding and recurrent endometrial polyp. MASO is a rare type of uterine sarcomas, it is a variant of adenosarcomas with poor prognosis.
The index patient underwent primary surgical management with lymphadenectomy with a final stage of IC. Histologic diagnosis was Mulllerian adenosarcoma with sarcomatous overgrowth. A panel of immunostaining for estrogen receptors, progesterone receptors and CD 10 showed diffused positivity for the hormones with loss of CD 10 which is consistent with MASO.
The rarity of MASO has a distinctive histologic features which merits meticulous sectioning as the clinical course and management vary. It has a poor prognosis due to its short and fast course of the disease.
Adenosarcoma
;
Sarcoma
;
Uterine Neoplasms
;
Soft Tissue Neoplasms